Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease save search
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
DGX | $126.98 -0.35% -0.18% 890K
|
Health Services
|
| O: 0.26%
H: 0.1%
C: -0.58%
disease test blood alzheimer's imaging study
United States Food & Drug Administration Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease
Published: 2024-03-26 (Crawled : 07:00) - biospace.com/
MESO | $5.03 7.25% 6.76% 500K
|
Health Technology
|
| O: 23.18%
H: 0.0%
C: 0.0%
drug disease children food trial submission
United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
Published: 2024-03-26 (Crawled : 03:00) - globenewswire.com
MESO | $5.03 7.25% 6.76% 500K
|
Health Technology
|
| O: 23.18%
H: 0.0%
C: 0.0%
drug disease children food trial submission
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
TNXP | $0.1581 5.47% 5.19% 2M
|
Health Technology
|
| O: 0.0%
H: 0.03%
C: -5.2%
tnx-2900 fda rare disease treatment pharmaceuticals designation
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
APGE | $51.46 1.58% 1.55% 440K
|
|
| O: 0.6%
H: 2.5%
C: -5.58%
apg808 first disease antibody treatment trial therapeutics
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Published: 2024-03-25 (Crawled : 10:00) - globenewswire.com
NVO | News | $124.53 0.88% 0.0% 2.6M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
disease pipeline pharmaceuticals acquire cardiovascular
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Published: 2024-03-22 (Crawled : 18:00) - prnewswire.com
NKTR | News | $1.345 -9.73% -10.78% 3.3M
|
Health Technology
| Email alert
Add to watchlist
management conference disease
Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
Published: 2024-03-22 (Crawled : 13:00) - biospace.com/
EQ | $1.85 0.0% 93K
|
Health Technology
|
| O: -1.81%
H: 9.74%
C: 3.68%
conference disease
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
Published: 2024-03-22 (Crawled : 12:00) - globenewswire.com
BLTE | $32.38 -9.75% -10.81% 28K
|
n/a
|
| O: -1.17%
H: 2.06%
C: 1.6%
disease japan trial submission
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
Published: 2024-03-22 (Crawled : 02:00) - globenewswire.com
MYGN | News F | $18.66 -1.37% -1.39% 550K
|
Health Technology
|
| O: 0.13%
H: 0.69%
C: -0.4%
patent disease granted molecular
Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Published: 2024-03-21 (Crawled : 21:00) - globenewswire.com
JSPR | $23.695 -1.97% -2.0% 72K
|
|
| O: 1.31%
H: 0.35%
C: -2.76%
conference disease therapeutics
Vertex Announces FDA Clearance of Investigational New Drug Application for VX-407 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2024-03-21 (Crawled : 21:00) - biospace.com/
VRTX | $393.1 -0.27% -0.27% 880K
|
Health Technology
|
| O: 0.85%
H: 0.88%
C: 0.02%
vx-407 fda drug disease kidney treatment clearance application
Suburban Propane and American Red Cross Partner with Sickle Cell Disease Association of Illinois to Boost Sickle Cell Awareness in Chicago
Published: 2024-03-21 (Crawled : 19:00) - prnewswire.com
SPH | $19.09 2.91% 1.26% 170K
|
Utilities
|
| O: -0.1%
H: 0.0%
C: -1.9%
disease association cell
Global OTC/DTC Infectious Disease Diagnostics Market Research Report 2024 with Guides for Executives and Marketing Staff, & Investment Analysts and Management Consultants
Published: 2024-03-21 (Crawled : 18:00) - prnewswire.com
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: -0.01%
H: 1.22%
C: 0.71%
BDX | $232.21 0.52% -0.52% 1.5M
|
Health Technology
|
| O: 0.46%
H: 1.26%
C: 1.11%
OSUR | $5.25 0.58% 0.57% 1.1M
|
Health Technology
|
| O: -0.15%
H: 1.08%
C: -2.61%
management disease report research global diagnostics market
Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
LSTA | $2.84 -5.82% 6.7K
|
Manufacturing
|
| O: 0.32%
H: 9.68%
C: 8.06%
fda rare disease granted treatment designation therapeutics
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
Published: 2024-03-20 (Crawled : 14:00) - biospace.com/
LUCD | $0.7962 -2.31% -2.36% 38K
|
|
| O: -0.93%
H: 3.74%
C: 3.74%
PAVM | $1.87 -1.33% 31K
|
Health Technology
|
| O: 1.95%
H: 14.83%
C: 5.74%
conference disease week diagnostics
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
Published: 2024-03-20 (Crawled : 12:00) - biospace.com/
ANVS | $9.07 -10.02% -0.06% 280K
|
Health Technology
|
| O: 10.43%
H: 34.62%
C: 12.69%
announcement disease alzheimer’s update buntanetap study
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease
Published: 2024-03-20 (Crawled : 11:00) - globenewswire.com
SLRN | $5.02 -2.34% -2.39% 600K
|
|
| O: 2.39%
H: 5.4%
C: 2.09%
first disease positive thyroid eye
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
Published: 2024-03-20 (Crawled : 11:00) - prnewswire.com
LH M | $199.97 -0.97% 0.0% 680K
|
Health Services
|
| O: -0.32%
H: 0.29%
C: -0.45%
disease test biomarker blood trials alzheimer's
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Published: 2024-03-19 (Crawled : 15:30) - biospace.com/
HOTH | $1.19 -0.83% -0.84% 24K
|
Health Technology
|
| O: 21.74%
H: 19.29%
C: -3.57%
disease pre-clinical positive treatment alzheimer's therapeutics ht-alz study
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.